Abstract
Neutrophil elastase, proteinase 3, and cathepsin G are three hematopoietic serine proteases, large quantities of which are stored in neutrophil cytoplasmic azurophilic granules. They act in combination with reactive oxygen species to degrade engulfed microorganisms inside phagolysosomes. Active forms of these proteases are also externalized during neutrophil activation at inflammatory sites, thus helping to regulate inflammatory and immune responses. A fraction of secreted neutrophil serine proteases (NSPs) remains bound to the external plasma membrane, where they remain enzymatically active. This protocol describes the spectrofluorometric measurement of NSP activities using sensitive ortho-aminobenzoyl-peptidyl-N-(2,4-dinitrophenyl) ethylenediamine fluorescence resonance energy transfer (FRET) substrates that fully discriminate between the three human NSPs. These are used to measure subnanomolar concentrations of free or membrane-bound NSPs in low-binding microplates and to quantify the activities of individual proteases in biological fluids. We describe the synthesis of FRET substrate, neutrophil purification, and kinetic experiments on activated neutrophils. The protocol for measuring NSP activity on the surface of activated neutrophils can be adapted to measure NSP activities in whole biological fluids. Such data clarify the contributions of individual NSPs to the development of inflammatory diseases. Ultimately, these proteases may be shown to be targets for therapeutic inhibitors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Hedstrom, L. (2002) Serine protease mechanism and specificity, Chem Rev 102, 4501–4523.
Heutinck, K. M., ten Berge, I. J., Hack, C. E. et al. (2010) Serine proteases of the human immune system in health and disease, Mol Immunol 47, 1943–1955.
Korkmaz, B., Horwitz, M. S., Jenne, D. E. et al. (2010) Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases, Pharmacol Rev 62, 726–759.
Segal, A. W. (2005) How neutrophils kill microbes, Annu Rev Immunol 23, 197–223.
Owen, C. A., Campbell, E. J. (1999) The cell biology of leukocyte-mediated proteolysis, J Leukoc Biol 65, 137–150.
Campbell, E. J., Campbell M. A., Owen, C. A. (2000) Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition, J Immunol 165, 3366–3374.
Owen, C. A., Campbell, M. A., Boukedes, S. S. et al. (1995) Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G, J Immunol 155, 5803–5810.
Owen, C. A., Campbell, M. A., Boukedes, S. S. et al. (1997) Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity, Am J Physiol 272, L385-393.
Halbwachs-Mecarelli, L., Bessou, G., Lesavre, P. et al. (1995) Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool, FEBS Lett 374, 29–33.
Schreiber, A., Busjahn, A. Luft, F. C. et al. (2003) Membrane expression of proteinase 3 is genetically determined, J Am Soc Nephrol 14, 68–75.
Lee, W. L., and Downey, G. P. (2001) Leukocyte elastase: physiological functions and role in acute lung injury, Am J Respir Crit Care Med 164, 896–904.
Shapiro, S. D. (2002) Proteinases in chronic obstructive pulmonary disease, Biochem Soc Trans 30, 98–102.
Moraes, T. J., Chow, C. W., Downey, G. P. (2003) Proteases and lung injury, Crit Care Med 31, S189–194.
Owen, C. A. (2008) Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease, Int J Chron Obstruct Pulmon Dis 3, 253–268.
Horwitz, M., Benson, K. F., Person, R. E. et al. (1999) Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis, Nat Genet 23, 433–436.
Horwitz, M. S., Duan, Z. Korkmaz, B. et al. (2007) Neutrophil elastase in cyclic and severe congenital neutropenia, Blood 109, 1817–1824.
Jenne, D. E., Tschopp, J., Ludemann J. et al. (1990) Wegener’s autoantigen decoded, Nature 346, 520.
Korkmaz, B., Attucci, S., Jourdan, M. L. et al. (2005) Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils, J Immunol 175, 3329–3338.
Korkmaz, B., Jaillet, J., Jourdan, M. L. et al. (2009) Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J Biol Chem 284, 19896–19902.
Kaiser, E., Colescott, R. L., Bossinger, C. D. et al. (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides, Anal Biochem 34, 595–598.
Coin, I., Beyermann, M., Bienert, M. (2007) Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences, Nat Protoc 2, 3247–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Korkmaz, B. et al. (2012). Measurement of Neutrophil Elastase, Proteinase 3, and Cathepsin G Activities using Intramolecularly Quenched Fluorogenic Substrates. In: Ashman, R. (eds) Leucocytes. Methods in Molecular Biology, vol 844. Humana Press. https://doi.org/10.1007/978-1-61779-527-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-61779-527-5_9
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-526-8
Online ISBN: 978-1-61779-527-5
eBook Packages: Springer Protocols